These results suggested that the protective effect of the IL8rs2227307 SNP on AML risk might be mediated by TLR2-induced immune responses that are initially regulating IL1β secretion and, subsequently, IL8 production in a wide range of pathological conditions32–35. Here, CXCL8 is linked to acute myeloid leukemia.